NCT06336135

Reduction in Symptoms After Laser Therapy With Acorn aHFS

A Prospective, Single-blind, Randomized, Placebo-controlled, Clinical Trial Evaluating Reduction in Severity and Duration of Symptoms After Laser Therapy With Acorn aHFS

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 11 (actual)
• Sponsor: Acorn Biolabs Inc. · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the severity and duration of symptoms experienced after laser therapy comparing four post-procedure topical products. Each product is applied to an individual region of interest (5 cm diameter) on the back or décolleté according to randomization code after laser therapy. The subject, blind to the product applied to each of 4 regions of interest, assesses eight symptoms daily for 14 days. Photography is performed daily.

Conditions

• Skin Aging

Interventions

Type	Name	Description
OTHER	autologous hair follicle derived secretome	aHFS is a cosmetic topical intended to be applied to the human body after skin resurfacing cosmetic procedures. aHFS is produced from the plucked hair follicles of each individual, making it autologous.

Timeline

• Start date: 2024-03-25
• Primary completion: 2025-12-02
• Completion: 2025-12-02
• First posted: 2024-03-28
• Last updated: 2025-12-12

Locations

1 site across 1 country: Canada